| A Clinical Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride for Sedation/Anesthesia During Gastroscopy/Colonoscopy (NCT06858852) | Ahon Pharmaceutical Co., Ltd. | 2025-03-01 |
| A Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride in Gastroscopy/Colonoscopy (NCT06682546) | Ahon Pharmaceutical Co., Ltd. | 2024-11-15 |
| Safety and Pharmacokinetics/ Pharmacodynamics of Methoxyethyl Etomidate Hydrochloride in Healthy Elderly Subjects (NCT06764147) | Ahon Pharmaceutical Co., Ltd. | 2023-12-25 |
| Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride (NCT06176716) | Ahon Pharmaceutical Co., Ltd. | 2023-12-06 |
| Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride (NCT06822166) | Ahon Pharmaceutical Co., Ltd. | 2023-12-04 |
| Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride (NCT06747520) | Ahon Pharmaceutical Co., Ltd. | 2023-11-30 |
| Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the Heart (NCT06822153) | Ahon Pharmaceutical Co., Ltd. | 2023-11-09 |
| A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects (NCT06203431) | Ahon Pharmaceutical Co., Ltd. | 2023-10-11 |
| Clinical Trial of FCN-437c Capsule in Patients With Hepatic Insufficiency (NCT06620731) | Ahon Pharmaceutical Co., Ltd. | 2023-09-04 |
| Substance Balance Trial of Methoxyethyl Etomidate Hydrochloride (NCT06822114) | Ahon Pharmaceutical Co., Ltd. | 2023-07-17 |
| Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects (NCT06290466) | Ahon Pharmaceutical Co., Ltd. | 2022-11-11 |
| This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. (NCT05439499) | Ahon Pharmaceutical Co., Ltd. | 2022-03-02 |
| Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin (NCT05004142) | Ahon Pharmaceutical Co., Ltd. | 2020-06-30 |
| Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c (NCT04488107) | Ahon Pharmaceutical Co., Ltd. | 2019-02-14 |
| A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation (NCT03420079) | Ahon Pharmaceutical Co., Ltd. | 2018-08-01 |